The FDA has issued 510(k) clearance for the epithelial thickness mapping application for the Cirrus HD-OCT platform, Carl Zeiss Meditec announced in a press release.
The mapping capability expands the anterior segment capabilities of the platform, allowing for assessment before refractive surgery, monitoring of response to treatment and management of ocular surface disorders and progressive corneal diseases.
The epithelial thickness mapping application is a quick non-contact exam that takes less than 1 second, the release said.
“The addition of this new software is another testament of our
Uncategorized